Early Commercial Experience With Clear Hydrogel Corneal Inlay: Comparative Look With Monovision LASIK

Saturday, April 26, 2014: 1:41 PM
Room 155 (Boston Convention and Exhibition Center)
Cornelis Verdoorn, MD, lasikcentrum, boxtel, Netherlands

Narrative Responses:

Purpose
To report my early commercial experience with Raindrop Near Vision Inlay for the treatment of presbyopia and to compare retrospectively with my monovision LASIK patients.

Methods
Nine (n=9) subjects were implanted with the Raindrop Near Inlay after creating a corneal flap of 150 microns and 8 mm diameter with the 150 kHz IntraLase femtosecond laser. Concurrent laser ablation was performed in 7 subjects with a (+0.50 D) target refraction in the inlay eye. The postop regimen of steriod eyedrops is essential to prevent foreign body reaction of the inlay. Visual acuity for far and near was tested at several time points. Results will be compared retrospectively to an age-matched cohort of monovision LASIK patients

Results
At 3 months, both Raindrop and monovision patients achieve (binocular) 20/25 or better uncorrected near and 20/20 or better uncorrected distance. Monocular UDVA is better in eyes implanted with Raindrop (20/40 or better achieved by 67% of Raindrop eyes compared to 36% in monovision traeted eye). Best corrected distance vision remained stable for both cohorts from preop to postop. Quality of life, satisfaction and spectacle indepandence will be presented at the meeting.

Conclusion
In my early experience, the Raindrop inlay provides similar near vision improvement as monovision but without distance vision impairment. The outcomes demostrate that the raindrop is a viable commercial product for the correction of presbyopia.